190 related articles for article (PubMed ID: 19298520)
1. p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysis.
Guan X; Wang Y; Xie R; Chen L; Bai J; Lu J; Kuo MT
J Cell Mol Med; 2010 Apr; 14(4):944-53. PubMed ID: 19298520
[TBL] [Abstract][Full Text] [Related]
2. [P27Kip1 expression and its prognostic implication in breast carcinoma: a meta-analysis].
Xie RL; Guan XX; Chen LB; Wang JH; Bai JL; Zhu BL; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):92-8. PubMed ID: 18681319
[TBL] [Abstract][Full Text] [Related]
3. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
[TBL] [Abstract][Full Text] [Related]
4. ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab.
Kurozumi S; Inoue K; Takei H; Matsumoto H; Kurosumi M; Horiguchi J; Takeyoshi I; Oyama T
BMC Cancer; 2015 Sep; 15():622. PubMed ID: 26345461
[TBL] [Abstract][Full Text] [Related]
5. p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
Stendahl M; Nilsson S; Wigerup C; Jirström K; Jönsson PE; Stål O; Landberg G
Int J Cancer; 2010 Dec; 127(12):2851-8. PubMed ID: 21351264
[TBL] [Abstract][Full Text] [Related]
6. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
[TBL] [Abstract][Full Text] [Related]
7. Loss of p27
Kim GJ; Kim DH; Min KW; Kim YH; Oh YH
Pathol Res Pract; 2018 Apr; 214(4):565-571. PubMed ID: 29482985
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer.
Schmider-Ross A; Pirsig O; Gottschalk E; Denkert C; Lichtenegger W; Reles A
J Cancer Res Clin Oncol; 2006 Mar; 132(3):163-70. PubMed ID: 16328436
[TBL] [Abstract][Full Text] [Related]
9. Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.
Chappuis PO; Kapusta L; Bégin LR; Wong N; Brunet JS; Narod SA; Slingerland J; Foulkes WD
J Clin Oncol; 2000 Dec; 18(24):4045-52. PubMed ID: 11118465
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle dysregulation influences survival in high risk breast cancer patients.
Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
[TBL] [Abstract][Full Text] [Related]
11. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M
Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210
[TBL] [Abstract][Full Text] [Related]
12. p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.
Porter PL; Barlow WE; Yeh IT; Lin MG; Yuan XP; Donato E; Sledge GW; Shapiro CL; Ingle JN; Haskell CM; Albain KS; Roberts JM; Livingston RB; Hayes DF
J Natl Cancer Inst; 2006 Dec; 98(23):1723-31. PubMed ID: 17148774
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
14. [Expression of PTEN protein and its correlation with p27kip1 and cyclin D1 expression in primary breast cancer].
Lin Q; Zhuang YZ; Xu DP; Ye JX; Chen PQ
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):246-9. PubMed ID: 12839686
[TBL] [Abstract][Full Text] [Related]
15. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
[TBL] [Abstract][Full Text] [Related]
16. 111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.
Cornelissen B; Kersemans V; McLarty K; Tran L; Reilly RM
Cancer Biother Radiopharm; 2009 Apr; 24(2):163-73. PubMed ID: 19409037
[TBL] [Abstract][Full Text] [Related]
17. p27(kipl) protein expression: an independent prognostic factor in rectal carcinoma stages I-III.
Pucciarelli ; Esposito ; Fassina ; Alaggio ; Masin ; Toppan ; Chieco-Bianchi ; Lise
Colorectal Dis; 1999 Nov; 1(6):315-23. PubMed ID: 23574593
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
[TBL] [Abstract][Full Text] [Related]
19. Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer.
Pertia A; Nikoleishvili D; Trsintsadze O; Gogokhia N; Managadze L; Chkhotua A
Int Urol Nephrol; 2007; 39(2):381-7. PubMed ID: 17310312
[TBL] [Abstract][Full Text] [Related]
20. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
Foekens JA; Peters HA; Look MP; Portengen H; Schmitt M; Kramer MD; Brünner N; Jänicke F; Meijer-van Gelder ME; Henzen-Logmans SC; van Putten WL; Klijn JG
Cancer Res; 2000 Feb; 60(3):636-43. PubMed ID: 10676647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]